As discussed in Note 1, revenues are recognized under guidance within ASC 606. The following table presents our disaggregated revenues for the periods presented (in thousands):


	For the Years Ended, December 31,
	2025		2024		2023
JAKAFI revenues, net	$	3,092,515	$	2,792,107	$	2,593,732
OPZELURA revenues, net	678,455		508,293		337,864
ICLUSIG revenues, net	134,071		114,319		111,623
MINJUVI/MONJUVI revenues, net	144,578		119,236		37,057
PEMAZYRE revenues, net	86,727		81,748		83,642
NIKTIMVO revenues, net	151,636		—		—
ZYNYZ revenues, net	66,351		3,185		1,250
Total product revenues, net	4,354,333		3,618,888		3,165,168
JAKAVI product royalty revenues	457,729		418,840		367,583
OLUMIANT product royalty revenues	144,600		135,572		136,138
TABRECTA product royalty revenues	26,702		22,746		17,793
Other product royalty revenues	7,878		2,171		1,967
Total product royalty revenues	636,909		579,329		523,481
Milestone and contract revenues	150,000		43,000		7,000
Total revenues	$	5,141,242	$	4,241,217	$	3,695,649